Single-dose therapy with trimethoprim-sulfametrole for chancroid in females

dc.contributor.author	Dylewski, J
dc.contributor.author	D'Costa, LJ
dc.contributor.author	Nsanze, H
dc.contributor.author	Ronald, AR
dc.date.accessioned	2013-06-11T06:57:21Z
dc.date.available	2013-06-11T06:57:21Z
dc.date.issued	1986-09
dc.identifier.citation	Sex Transm Dis. 1986 Jul-Sep;13(3):166-8.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/3764627
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/31134
dc.description.abstract	Women with genital ulcer disease who were culture-positive for Haemophilus ducreyi were treated with a single dose of the drug combination trimethoprim-sulfametrole; the dosage was 640 mg of trimethoprim and 3,200 mg of sulfametrole. All 27 women who were treated with this regimen and adequately followed were cured. Thus a single dose of trimethoprim-sulfametrole appears to be an effective treatment regimen for women with chancroid in Kenya.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi,	en
dc.title	Single-dose therapy with trimethoprim-sulfametrole for chancroid in females	en
dc.type	Article	en
local.publisher	Department of Medicine	en